Lai Wei

Lai Wei, Ryan McCloy, Jie Bao

In response to the continuously changing feedstock supply and market demand for products with different specifications, the processes need to be operated at time-varying operating conditions and targets (e.g., setpoints) to improve the process economy, in contrast to traditional process operations around predetermined equilibriums. In this paper, a contraction theory-based control approach using neural networks is developed for nonlinear chemical processes to achieve time-varying reference tracking. This approach leverages the universal approximation characteristics of neural networks with discrete-time contraction analysis and control. It involves training a neural network to learn a contraction metric and differential feedback gain, that is embedded in a contraction-based controller. A second, separate neural network is also incorporated into the control-loop to perform online learning of uncertain system model parameters. The resulting control scheme is capable of achieving efficient offset-free tracking of time-varying references, with a full range of model uncertainty, without the need for controller structure redesign as the reference changes. This is a robust approach that can deal with bounded parametric uncertainties in the process model, which are commonly encountered in industrial (chemical) processes. This approach also ensures the process stability during online simultaneous learning and control. Simulation examples are provided to illustrate the above approach.

Ruoqi Liu, Lai Wei, Ping Zhang

Drug repurposing is an effective strategy to identify new uses for existing drugs, providing the quickest possible transition from bench to bedside. Existing methods for drug repurposing that mainly focus on pre-clinical information may exist translational issues when applied to human beings. Real world data (RWD), such as electronic health records and insurance claims, provide information on large cohorts of users for many drugs. Here we present an efficient and easily-customized framework for generating and testing multiple candidates for drug repurposing using a retrospective analysis of RWDs. Building upon well-established causal inference and deep learning methods, our framework emulates randomized clinical trials for drugs present in a large-scale medical claims database. We demonstrate our framework in a case study of coronary artery disease (CAD) by evaluating the effect of 55 repurposing drug candidates on various disease outcomes. We achieve 6 drug candidates that significantly improve the CAD outcomes but not have been indicated for treating CAD, paving the way for drug repurposing.